FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

708822004: Secukinumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3037500017 Secukinumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3037626016 Secukinumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
72691000195112 Secukinumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
839651000172119 sécukinumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
57511000195115 secukinumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Secukinumab Is a Immunosuppressant (substance) true Inferred relationship Some
Secukinumab Is a agent d'anticorps monoclonal false Inferred relationship Some
Secukinumab Is a Monoclonal antibody true Inferred relationship Some
Secukinumab Has disposition (attribute) Immunomodulator (disposition) true Inferred relationship Some
Secukinumab Is a anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing secukinumab (medicinal product) Has active ingredient True Secukinumab Inferred relationship Some 1
Secukinumab only product Has active ingredient True Secukinumab Inferred relationship Some 1
Product containing secukinumab in parenteral dose form (medicinal product form) Has active ingredient True Secukinumab Inferred relationship Some 1
Secukinumab only product in parenteral dose form Has active ingredient True Secukinumab Inferred relationship Some 1
Secukinumab therapy (procedure) Direct substance True Secukinumab Inferred relationship Some 1
Secukinumab 150 mg/mL solution for injection Has precise active ingredient True Secukinumab Inferred relationship Some 1
Secukinumab 150 mg/mL solution for injection Has basis of strength substance (attribute) True Secukinumab Inferred relationship Some 1

This concept is not in any reference sets

Back to Start